Find clinical trials for Parkinson's Disease. Search for oncology clinical trials in different cities and states across the United States.
Sponsor:
AbbVie
Location:
Code:
NCT06107426
Conditions
Parkinson's Disease (PD)
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Sponsor:
McGill University
Location:
Code:
NCT05644327
Conditions
Parkinson Disease
Eligibility Criteria
Sex: All
Age: 40+
Healthy Volunteers: Not accepted
Interventions
Cardiovascular training (CT)
Resistance training (RT)
Multimodal training (MT)
Sponsor:
University of Florida
Location:
Code:
NCT04725773
Conditions
Deep Brain Stimulation
Parkinson Disease
Apraxia, Motor
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Deep brain stimulation effect on apraxia
Sponsor:
Intec Pharma Ltd.
Location:
Code:
NCT02615873
Conditions
Parkinson's Disease
Eligibility Criteria
Sex: All
Age: 30 - 70+
Healthy Volunteers: Not accepted
Interventions
Accordion Pill™ Carbidopa/Levodopa
Sponsor:
University of Miami
Location:
Code:
NCT06194227
Conditions
Cognitive Change
Eligibility Criteria
Sex: All
Age: 50 - 70+
Healthy Volunteers: Not accepted
Interventions
High-speed, Cognitive Challenge Yoga
Traditional Yoga
Sponsor:
University of Minnesota
Location:
Code:
NCT06692920
Conditions
Parkinson Disease
Eligibility Criteria
Sex: All
Age: 21 - 70+
Healthy Volunteers: Not accepted
Interventions
DBS stimulation
Sponsor:
University of Kansas Medical Center
Location:
Code:
NCT03969927
Conditions
Parkinson Disease
Multiple Sclerosis
Stroke
Eligibility Criteria
Sex: All
Age: 25 - 70+
Healthy Volunteers: Not accepted
Interventions
Low-Fidelity PDS
High Fidelity Fixed-Base Simulator
Clinical trials for Parkinson’s disease are research studies conducted to evaluate the safety and effectiveness of new treatments for Parkinson's disease. These trials test new drugs, surgical procedures, or therapies to determine whether they offer benefits over existing treatments. The goal is to find more effective ways to manage the symptoms, slow down the progression, or potentially cure this disease.
Clinical trials play a crucial role in developing new treatments for Parkinson's disease. They allow researchers to test the efficacy and safety of innovative therapies, medications, and interventions in controlled environments. Data gathered from these trials help in identifying treatments that can improve the quality of life for those living with Parkinson’s disease, offering hope for more effective management of the disease's symptoms and progression.
Parkinson's disease clinical trials explore a wide range of treatments aimed at improving the lives of those affected by the condition. These treatments fall under 3 key types of studies:
Many clinical trials for Parkinson's disease focus on testing new medications designed to improve symptoms, slow disease progression, or manage side effects more effectively. These trials may explore different drugs to determine their effectiveness, optimal dosages, and combinations to find the most beneficial treatments.
Some clinical trials examine the efficacy of surgical interventions, such as deep brain stimulation (DBS), or the use of medical devices that can alleviate symptoms or improve motor function in patients with Parkinson's disease. These studies aim to refine surgical techniques and develop innovative devices to enhance treatment outcomes.
Parkinson’s disease research also extends to non-pharmacological therapies, such as physical therapy, exercise, dietary changes, and cognitive-behavioral therapy. These trials investigate how lifestyle modifications and alternative therapies can contribute to managing Parkinson's disease symptoms and improving overall well-being.
Eligibility for Parkinson's disease trials varies depending on the study's specific requirements. Generally, individuals diagnosed with Parkinson's disease at various stages of the disease may qualify. Criteria might include age, disease severity, medication history, and overall health status. Some trials might also be open to individuals without Parkinson's for preventive studies or to compare health outcomes.
Participants can expect to undergo a thorough screening process to determine eligibility, followed by detailed information about the study's purpose, procedures, potential risks, and benefits. During the trial, participants might receive specific interventions and be closely monitored through regular health assessments and follow-ups to evaluate the treatment's effectiveness and any side effects.
Worried about the risks of participating in a clinical trial? Delve into our comprehensive guide to gain insights into the potential outcomes of participating. Learn about potential risks, benefits, and safety considerations to make an informed decision about your participation in a clinical trial.
Enrolling in a clinical trial for Parkinson’s disease through our platform is a straightforward and user-friendly process. Here's how to get started: